This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Centers for Disease Control and Prevention. What is Hemophilia? 2022. Available from https://www.cdc.gov/ncbddd/hemophilia/facts.html (accessed January 2023).Centers for Disease Control and Prevention.2022. Available from https://www.cdc.gov/ncbddd/hemophilia/facts.html (accessed January 2023).Search in Google Scholar
Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: Modelisation of the clinical pathway for patients. Int J Environ Res Public Health 2022; 19(2): 646. doi: 10.3390/ijerph19020646.BenyKdu Sartz de VigneullesBCarrouelFHaemophilia in France: Modelisation of the clinical pathway for patients.2022; 19(2): 646. doi: 10.3390/ijerph19020646.Open DOISearch in Google Scholar
Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26 Suppl 6: 1-158. doi: 10.1111/hae.14046.SrivastavaASantagostinoEDougallA, 3rd edition. Haemophilia2020; 26Suppl 6: 1-158. doi: 10.1111/hae.14046.Open DOISearch in Google Scholar
Mehta P, Reddivari AKR. Hemophilia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 30 Sep 2022.MehtaPReddivariAKR.Hemophilia. In: [Internet]. Treasure Island (FL): StatPearls Publishing; 30Sep2022.Search in Google Scholar
Roche. Summary of Product Characteristics – Hemlibra. Available from https://www.ema.europa.eu/en/documents/product-information/hemlibra-epar-product-information_en.pdf (accessed March 2023).Roche.. Available from https://www.ema.europa.eu/en/documents/product-information/hemlibra-epar-product-information_en.pdf (accessed March 2023).Search in Google Scholar
Genentech. Prescribing Information – HEMLIBRA. Available from https://www.gene.com/download/pdf/hemlibra_prescribing.pdf (accessed March 2023).Genentech.. Available from https://www.gene.com/download/pdf/hemlibra_prescribing.pdf (accessed March 2023).Search in Google Scholar
Leebeek FWG, Miesbach W. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Blood 2021; 138(11): 923-931. doi: 10.1182/blood.2019003777.LeebeekFWGMiesbachW.Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. 2021; 138(11): 923-931. doi: 10.1182/blood.2019003777.Open DOISearch in Google Scholar
BioMarin. Summary of Product Characteristics – ROCTAVIAN. Available from https://www.ema.europa.eu/en/documents/product-information/roctavian-epar-product-information_en.pdf (accessed March 2023).BioMarin.. Available from https://www.ema.europa.eu/en/documents/product-information/roctavian-epar-product-information_en.pdf (accessed March 2023).Search in Google Scholar
BioMarin. Prescribing Information – ROCTAVIAN. Available from https://d34r3hkxgxjdtw.cloudfront.net/6f836309-d95f-42af-b717-2efa058ad82d/78bf2bcb-7068-4774-b962-a35c53704fc1/78bf2bcb-7068-4774-b962-a35c53704fc1_source__v.pdf (accessed July 2023).BioMarin.. Available from https://d34r3hkxgxjdtw.cloudfront.net/6f836309-d95f-42af-b717-2efa058ad82d/78bf2bcb-7068-4774-b962-a35c53704fc1/78bf2bcb-7068-4774-b962-a35c53704fc1_source__v.pdf (accessed July 2023).Search in Google Scholar
CSL Behring. Prescribing Information – HEMGENIX. Available from https://labeling.cslbehring.com/PI/US/Hemgenix/EN/Hemgenix-Prescribing-Information.pdf (accessed January 2023).CSL Behring.. Available from https://labeling.cslbehring.com/PI/US/Hemgenix/EN/Hemgenix-Prescribing-Information.pdf (accessed January 2023).Search in Google Scholar
CSL Behring. Summary of Product Characteristics - Hemgenix. Available from https://www.ema.europa.eu/en/documents/product-information/hemgenix-epar-product-information_en.pdf (accessed March 2023).CSL Behring.. Available from https://www.ema.europa.eu/en/documents/product-information/hemgenix-epar-product-information_en.pdf (accessed March 2023).Search in Google Scholar
Medicines and Healthcare products Regulatory Agency. Orphan Registered Medicinal Products: HEMGENIX. 2023. Available from https://www.gov.uk/government/publications/orphan-registered-medicinal-products/orphan-register#hemgenix-1-x-1013-genome-copiesml-concentrate-for-solution-for-infusion (accessed July 2023).Medicines and Healthcare products Regulatory Agency..2023. Available from https://www.gov.uk/government/publications/orphan-registered-medicinal-products/orphan-register#hemgenix-1-x-1013-genome-copiesml-concentrate-for-solution-for-infusion (accessed July 2023).Search in Google Scholar
Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev 2021; 52: 100890. doi: 10.1016/j.blre.2021.100890.HermansCNooneDBensonGHemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. 2021; 52: 100890. doi: 10.1016/j.blre.2021.100890.Open DOISearch in Google Scholar
Krumb E, Hermans C. Living with a “hemophilia-free mind” – The new ambition of hemophilia care? Res Pract Thromb Haemost 2021; 5(5): e12567. doi: 10.1002/rth2.12567.KrumbEHermansC.Living with a “hemophilia-free mind” – The new ambition of hemophilia care?2021; 5(5): e12567. doi: 10.1002/rth2.12567.Open DOISearch in Google Scholar
O’Donovan M, Buckley C, Benson J, et al. Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemic. Haemophilia 2020; 26(6): 984-990. doi: 10.1111/hae.14156.O’DonovanMBuckleyCBensonJTelehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemic. 2020; 26(6): 984-990. doi: 10.1111/hae.14156.Open DOISearch in Google Scholar
McKinsey & Company. Telehealth: A quarter-trillion-dollar post-COVID-19 reality? 9 July 2021. Available from https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/telehealth-a-quarter-trillion-dollar-post-covid-19-reality (accessed July 2023).McKinsey & Company.9July2021. Available from https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/telehealth-a-quarter-trillion-dollar-post-covid-19-reality (accessed July 2023).Search in Google Scholar
de Kleijn P, Duport G, Jansone K, et al. European principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patients. Haemophilia 2022; 28(4): 649-655. doi: 10.1111/hae.14566.de KleijnPDuportGJansoneKEuropean principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patients. 2022; 28(4): 649-655. doi: 10.1111/hae.14566.Open DOISearch in Google Scholar
Timmer MA, Blokzijl J, Schutgens REG, Veenhof C, Pisters MF. Coordinating physiotherapy care for persons with haemophilia. Haemophilia 2021; 27(6): 1051-1061. doi: 10.1111/hae.14404.TimmerMABlokzijlJSchutgensREGVeenhofCPistersMF.Coordinating physiotherapy care for persons with haemophilia. 2021; 27(6): 1051-1061. doi: 10.1111/hae.14404.Open DOISearch in Google Scholar
Mulder K, McCabe E, Strike K, Nilson J. Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders. Haemophilia 2021; 27(4): 674-682. doi: 10.1111/hae.14327.MulderKMcCabeEStrikeKNilsonJ.Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders. 2021; 27(4): 674-682. doi: 10.1111/hae.14327.Open DOISearch in Google Scholar
Lee D, Le AO, Meganck M, Chamberland S, Pai A. Adding a clinical hemophilia pharmacist to the hemophilia comprehensive care model improves health care-related outcomes and drug-related costs in an integrated health care system. Perm J 2022; 26(3): 90-93. doi: 10.7812/TPP/21.192.LeeDLeAOMeganckMChamberlandSPaiA.Adding a clinical hemophilia pharmacist to the hemophilia comprehensive care model improves health care-related outcomes and drug-related costs in an integrated health care system. 2022; 26(3): 90-93. doi: 10.7812/TPP/21.192.Open DOISearch in Google Scholar
St-Louis J, Chowdary P, Dolan G, et al. Multidisciplinary team care of patients with hemophilic arthropathy: A qualitative assessment of contemporary practice in the UK and Canada : Canada/UK: MDT Practices for Hemophilia. Clin Appl Thromb Hemost 2022; 28: 10760296211070002. doi: 10.1177/10760296211070002.St-LouisJChowdaryPDolanGMultidisciplinary team care of patients with hemophilic arthropathy: A qualitative assessment of contemporary practice in the UK and Canada : Canada/UK: MDT Practices for Hemophilia. 2022; 28: 10760296211070002. doi: 10.1177/10760296211070002.Open DOISearch in Google Scholar
Valentino LA, Baker JR, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med 2021; 12: 897-911. doi: 10.2147/JBM.S325031.ValentinoLABakerJRButlerRIntegrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. 2021; 12: 897-911. doi: 10.2147/JBM.S325031.Open DOISearch in Google Scholar
Cortesi PA, Rocino A, Preti D, et al. Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view. Haemophilia 2022; 28(2): 254-263. doi: 10.1111/hae.14504.CortesiPARocinoAPretiDHaemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view. 2022; 28(2): 254-263. doi: 10.1111/hae.14504.Open DOISearch in Google Scholar
Gualtierotti R, Tafuri F, Arcudi S, et al. Current and emerging approaches for pain management in hemophilic arthropathy. Pain Ther 2022; 11: 1-15. doi: 10.1007/s40122-021-00345-x.GualtierottiRTafuriFArcudiSCurrent and emerging approaches for pain management in hemophilic arthropathy. 2022; 11: 1-15. doi: 10.1007/s40122-021-00345-x.Open DOISearch in Google Scholar
Ghosh K, Ghosh K. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence. Expert Rev Hematol 2021; 14(8): 721-730. doi: 10.1080/17474086.2021.1957826.GhoshKGhoshK.Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence. 2021; 14(8): 721-730. doi: 10.1080/17474086.2021.1957826.Open DOISearch in Google Scholar
Mbanya DN, Diop S, Ndoumba Mintya AN, El Kiaby M. Hemophilia care in Africa: Status and challenges. Transfus Clin Biol 2021; 28(2): 158-162. doi: 10.1016/j.tracli.2021.01.008.MbanyaDNDiopSNdoumba MintyaANEl KiabyM.Hemophilia care in Africa: Status and challenges. 2021; 28(2): 158-162. doi: 10.1016/j.tracli.2021.01.008.Open DOISearch in Google Scholar
Kulkarni R. Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. Haemophilia 2018; 24(1): 33-42. doi: 10.1111/hae.13364.KulkarniR.Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. 2018; 24(1): 33-42. doi: 10.1111/hae.13364.Open DOISearch in Google Scholar
Qian W, Lam TT, Lam HHW, Li CK, Cheung YT. Telehealth interventions for improving self-management in patients with hemophilia: Scoping review of clinical studies. J Med Internet Res 2019; 21(7): e12340. doi: 10.2196/12340.QianWLamTTLamHHWLiCKCheungYT.Telehealth interventions for improving self-management in patients with hemophilia: Scoping review of clinical studies. 2019; 21(7): e12340. doi: 10.2196/12340.Open DOISearch in Google Scholar
Jacobson K, Hooke MC. Telehealth videoconferencing for children with hemophilia and their families: a clinical project. J Pediatr Oncol Nurs 2016; 33(4): 282-288. doi: 10.1177/1043454215607340.JacobsonKHookeMC.Telehealth videoconferencing for children with hemophilia and their families: a clinical project. 2016; 33(4): 282-288. doi: 10.1177/1043454215607340.Open DOISearch in Google Scholar
Alvarez-Roman MT, Kurnik K, PedNet Study G. Care for children with haemophilia during COVID-19: Data of the PedNet study group. Haemophilia 2021; 27(4): e537-e539. doi: 10.1111/hae.14286.Alvarez-RomanMTKurnikKPedNet Study G.Care for children with haemophilia during COVID-19: Data of the PedNet study group. 2021; 27(4): e537-e539. doi: 10.1111/hae.14286.Open DOISearch in Google Scholar
Windyga J, Boban A, Zupan I, O’Connell N, Hermans C. Changing paradigms of hemophilia care across larger specialized treatment centers in the European region. Ther Adv Hematol 2022; 13: 20406207221088462. doi: 10.1177/20406207221088462.WindygaJBobanAZupanIO’ConnellNHermansC.Changing paradigms of hemophilia care across larger specialized treatment centers in the European region. 2022; 13: 20406207221088462. doi: 10.1177/20406207221088462.Open DOISearch in Google Scholar
Olusanya OA, Ammar N, Brakefield WS, et al. HemPHL: A personal health library and mHealth recommender to promote self-management of hemophilia. Stud Health Technol Inform 2021; 281: 550-554. doi: 10.3233/SHTI210231.OlusanyaOAAmmarNBrakefieldWSHemPHL: A personal health library and mHealth recommender to promote self-management of hemophilia. 2021; 281: 550-554. doi: 10.3233/SHTI210231.Open DOISearch in Google Scholar
Dirzu N, Hotea I, Jitaru C, et al. Mobile health technology for the personalized therapy of hemophilia. Front Med (Lausanne) 2021; 8: 711973. doi: 10.3389/fmed.2021.711973.DirzuNHoteaIJitaruCMobile health technology for the personalized therapy of hemophilia. 2021; 8: 711973. doi: 10.3389/fmed.2021.711973.Open DOISearch in Google Scholar
Sayers F, Manson H, Brennan B, et al. Virtual consultations: Providing alternative ways of supporting patients with inherited bleeding disorders. Haemophilia 2021; 27(4): e498-e501. doi: 10.1111/hae.14210.SayersFMansonHBrennanBVirtual consultations: Providing alternative ways of supporting patients with inherited bleeding disorders. 2021; 27(4):e498-e501. doi: 10.1111/hae.14210.Open DOISearch in Google Scholar
Aliaga-Castillo V, Horment-Lara G, Contreras-Sepúlveda F, Cruz-Montecinos C. Safety and effectiveness of telerehabilitation program in people with severe haemophilia in Chile. A qualitative study. Musculoskelet Sci Pract 2022; 60: 102565. doi: 10.1016/j.msksp.2022.102565.Aliaga-CastilloVHorment-LaraGContreras-SepúlvedaFCruz-MontecinosC.Safety and effectiveness of telerehabilitation program in people with severe haemophilia in Chile. A qualitative study. 2022; 60: 102565. doi: 10.1016/j.msksp.2022.102565.Open DOISearch in Google Scholar
Flannery T, Bladen M, Hopper D, et al. Physiotherapy after COVID-19-”Zoom or room”. Haemophilia 2021; 27(4): e476-e478. doi: 10.1111/hae.14166.FlanneryTBladenMHopperDPhysiotherapy after COVID-19-”Zoom or room”. 2021; 27(4): e476-e478. doi: 10.1111/hae.14166.Open DOISearch in Google Scholar
Lobet S, Timmer M, Königs C, et al. The role of physiotherapy in the new treatment landscape for haemophilia. J Clin Med 2021; 10(13): 2822. doi: 10.3390/jcm10132822.LobetSTimmerMKönigsCThe role of physiotherapy in the new treatment landscape for haemophilia. 2021; 10(13): 2822. doi: 10.3390/jcm10132822.Open DOISearch in Google Scholar
Banchev A, Goldmann G, Marquardt N, et al. Impact of telemedicine tools on record keeping and compliance in haemophilia care. Hamostaseologie 2019; 39(4): 347-354. doi: 10.1055/s-0038-1676128.BanchevAGoldmannGMarquardtNImpact of telemedicine tools on record keeping and compliance in haemophilia care. 2019; 39(4): 347-354. doi: 10.1055/s-0038-1676128.Open DOISearch in Google Scholar
Hay CRM, Xiang H, Scott M, et al. The Haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation. Haemophilia 2017; 23(5): 728-735. doi: 10.1111/hae.13287.HayCRMXiangHScottMThe Haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation. 2017; 23(5): 728-735. doi: 10.1111/hae.13287.Open DOISearch in Google Scholar
Tiede A, Bonanad S, Santamaria A, et al. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary. Haemophilia 2020; 26(6): 999-1008. doi: 10.1111/hae.14178.TiedeABonanadSSantamariaAQuality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary. 2020; 26(6): 999-1008. doi: 10.1111/hae.14178.Open DOISearch in Google Scholar
Cheung YT, Lam PH, Lam TT, Lam HHW, Li CK. Technology acceptance among patients with hemophilia in Hong Kong and their expectations of a mobile health app to promote self-management: Survey study. JMIR Form Res 2021; 5(9): e27985. doi: 10.2196/27985.CheungYTLamPHLamTTLamHHWLiCK.Technology acceptance among patients with hemophilia in Hong Kong and their expectations of a mobile health app to promote self-management: Survey study. 2021; 5(9): e27985. doi: 10.2196/27985.Open DOISearch in Google Scholar
Bhatt N, Boggio L, Simpson ML. Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B. Haemophilia 2021; 27(2): 229-236. doi: 10.1111/hae.14228.BhattNBoggioLSimpsonML.Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B. 2021; 27(2): 229-236. doi: 10.1111/hae.14228.Open DOISearch in Google Scholar
Zapata AC, Araya AX. Educational needs of parents of hemophiliac children: An approach to comprehensive care. Andes Pediatr 2021; 92(2): 219-225. doi: 10.32641/andespediatr.v92i2.1090.ZapataACArayaAX.Educational needs of parents of hemophiliac children: An approach to comprehensive care. 2021; 92(2): 219-225. doi: 10.32641/and espediatr.v92i2.1090.Open DOISearch in Google Scholar
Sun J, Zhou X, Hu N. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review. Orphanet J Rare Dis 2021; 16(1): 287. doi: 10.1186/s13023-021-01919-w.SunJZhouXHuN.Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review. 2021; 16(1): 287. doi: 10.1186/s13023-021-01919-w.Open DOISearch in Google Scholar
Mancuso ME, Male C, Kenet G, et al. Prophylaxis in children with haemophilia in an evolving treatment landscape. Haemophilia 2021; 27(6): 889-896. doi: 10.1111/hae.14412MancusoMEMaleCKenetGProphylaxis in children with haemophilia in an evolving treatment landscape. 2021; 27(6): 889-896. doi: 10.1111/hae.14412Open DOISearch in Google Scholar
Li CL, Strike K, Matino D, Bhatt M, Decker K, Chan AK. Telemedicine in hemophilia: A comprehensive review. Res Pract Thromb Haemost 2021; 5(S2): 451-452 (PB0597). Available from https://abstracts.isth.org/abstract/telemedicine-in-hemophilia-a-comprehensive-review/.LiCLStrikeKMatinoDBhattMDeckerKChanAK.Telemedicine in hemophilia: A comprehensive review. 2021; 5(S2): 451-452(PB0597). Available from https://abstracts.isth.org/abstract/telemedicine-in-hemophilia-a-comprehensive-review/.Search in Google Scholar